Home
About
Services
Partners
Client Portfolio
News
Contact
Tencent launches WeChat for drivers
August 26, 2019
Trump welcomes China’s call for ‘calm’ trade talks, wants same in Hong Kong
August 26, 2019
0
Celgene to sell psoriasis drug Otezla for $13.4 billion to Amgen
Published by
Muller&Green
at
August 26, 2019
Categories
RSS
Tags
Celgene Corp will sell its psoriasis drug Otezla for $13.4 billion in cash to Amgen Inc, taking Celgene a step closer to a $74-billion takeover by Bristol-Myers Squibb Co.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more